Jci_page_head_homepage_01 Jci_page_head_homepage_02
Steven E. Bosinger, Qingsheng Li, Shari N. Gordon, Nichole R. Klatt, Lijie Duan, Luoling Xu, Nicholas Francella, Abubaker Sidahmed, Anthony J. Smith, Elizabeth M. Cramer, Ming Zeng, David Masopust, John V. Carlis, Longsi Ran, Thomas H. Vanderford, Mirko Paiardini, R. Benjamin Isett, Don A. Baldwin, James G. Else, Silvija I. Staprans, Guido Silvestri, Ashley T. Haase, David J. Kelvin
Published in Volume 119, Issue 12
J Clin Invest. 2009; 119(12):3556 doi:10.1172/JCI40115
Abstract | Full text | PDF | Supplemental material
Citation information

Total citations by year in CrossRef

Year: 2012 2010 2009 Total
Citations: 1 1 1 3

Citations to this article in CrossRef (3)

Title and authors Publication Year
Blocking Type I Interferon Production: A New Therapeutic Option to Reduce the HIV-1-Induced Immune Activation
Moritz Ries, Kathrin Pritschet, Barbara Schmidt
Clinical and Developmental Immunology 2012
Innate immunity and chronic immune activation in HCV/HIV-1 co-infection
Veronica D. Gonzalez, Alan L. Landay, Johan K. Sandberg
Clinical Immunology 2010
Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response
Béatrice Jacquelin, Véronique Mayau, Brice Targat, Anne-Sophie Liovat, Désirée Kunkel, Gaël Petitjean, Marie-Agnès Dillies, Pierre Roques, Cécile Butor, Guido Silvestri, Luis D. Giavedoni, Pierre Lebon, Françoise Barré-Sinoussi, Arndt Benecke, Michaela C. Müller-Trutwin
J. Clin. Invest. 2009